249 related articles for article (PubMed ID: 17290307)
21. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
22. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycemia triggers HIPK2 protein degradation.
Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G
Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482
[TBL] [Abstract][Full Text] [Related]
24. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
25. Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression.
Möller A; Sirma H; Hofmann TG; Staege H; Gresko E; Lüdi KS; Klimczak E; Dröge W; Will H; Schmitz ML
Oncogene; 2003 Nov; 22(54):8731-7. PubMed ID: 14647468
[TBL] [Abstract][Full Text] [Related]
26. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
28. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
[TBL] [Abstract][Full Text] [Related]
29. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
[TBL] [Abstract][Full Text] [Related]
30. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S
Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959
[TBL] [Abstract][Full Text] [Related]
31. Heat shock modulates the subcellular localization, stability, and activity of HIPK2.
Upadhyay M; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2016 Apr; 472(4):580-4. PubMed ID: 26972256
[TBL] [Abstract][Full Text] [Related]
32. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer.
D'Orazi G; Rinaldo C; Soddu S
J Exp Clin Cancer Res; 2012 Aug; 31(1):63. PubMed ID: 22889244
[TBL] [Abstract][Full Text] [Related]
33. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.
Puca R; Nardinocchi L; Starace G; Rechavi G; Sacchi A; Givol D; D'Orazi G
Free Radic Biol Med; 2010 May; 48(10):1338-46. PubMed ID: 20171273
[TBL] [Abstract][Full Text] [Related]
34. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
[TBL] [Abstract][Full Text] [Related]
35. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
Muschik D; Braspenning-Wesch I; Stockfleth E; Rösl F; Hofmann TG; Nindl I
PLoS One; 2011; 6(11):e27655. PubMed ID: 22110707
[TBL] [Abstract][Full Text] [Related]
37. How cells switch HIPK2 on and off.
Sombroek D; Hofmann TG
Cell Death Differ; 2009 Feb; 16(2):187-94. PubMed ID: 18974774
[TBL] [Abstract][Full Text] [Related]
38. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.
Pierantoni GM; Rinaldo C; Esposito F; Mottolese M; Soddu S; Fusco A
Cell Death Differ; 2006 Sep; 13(9):1554-63. PubMed ID: 16341121
[TBL] [Abstract][Full Text] [Related]
39. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
Hofmann TG; Stollberg N; Schmitz ML; Will H
Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
[TBL] [Abstract][Full Text] [Related]
40. PARP1 regulates the protein stability and proapoptotic function of HIPK2.
Choi JR; Shin KS; Choi CY; Kang SJ
Cell Death Dis; 2016 Oct; 7(10):e2438. PubMed ID: 27787517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
